JP2019523302A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523302A5
JP2019523302A5 JP2019526209A JP2019526209A JP2019523302A5 JP 2019523302 A5 JP2019523302 A5 JP 2019523302A5 JP 2019526209 A JP2019526209 A JP 2019526209A JP 2019526209 A JP2019526209 A JP 2019526209A JP 2019523302 A5 JP2019523302 A5 JP 2019523302A5
Authority
JP
Japan
Prior art keywords
therapeutic
pharmaceutical composition
composition
seq
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019526209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019523302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/044731 external-priority patent/WO2018023126A1/en
Publication of JP2019523302A publication Critical patent/JP2019523302A/ja
Publication of JP2019523302A5 publication Critical patent/JP2019523302A5/ja
Priority to JP2022127495A priority Critical patent/JP2022169627A/ja
Pending legal-status Critical Current

Links

JP2019526209A 2016-07-29 2017-07-31 腋臭を治療する方法 Pending JP2019523302A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022127495A JP2022169627A (ja) 2016-07-29 2022-08-10 腋臭を治療する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662368896P 2016-07-29 2016-07-29
US62/368,896 2016-07-29
PCT/US2017/044731 WO2018023126A1 (en) 2016-07-29 2017-07-31 Methods of treating osmidrosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022127495A Division JP2022169627A (ja) 2016-07-29 2022-08-10 腋臭を治療する方法

Publications (2)

Publication Number Publication Date
JP2019523302A JP2019523302A (ja) 2019-08-22
JP2019523302A5 true JP2019523302A5 (enExample) 2020-09-17

Family

ID=61016798

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019526209A Pending JP2019523302A (ja) 2016-07-29 2017-07-31 腋臭を治療する方法
JP2022127495A Pending JP2022169627A (ja) 2016-07-29 2022-08-10 腋臭を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022127495A Pending JP2022169627A (ja) 2016-07-29 2022-08-10 腋臭を治療する方法

Country Status (5)

Country Link
US (3) US20210301289A1 (enExample)
EP (1) EP3491129A4 (enExample)
JP (2) JP2019523302A (enExample)
KR (1) KR20190123256A (enExample)
WO (1) WO2018023126A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021006102A (es) * 2018-12-03 2021-09-21 Eirion Therapeutics Inc Suministro mejorado de agentes grandes.
CN110124042A (zh) * 2019-05-28 2019-08-16 赵叶莲 不含铝的抑制腋臭的组合物
CN114341120A (zh) * 2019-08-21 2022-04-12 国立大学法人东京大学 Abcc11抑制剂
WO2021257630A2 (en) * 2020-06-15 2021-12-23 Cutler Richelle Drugs and methods for reducing body odor and sweat
WO2024104663A1 (en) 2022-11-16 2024-05-23 Unilever Ip Holdings B.V. Method of reducing malodour

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7148342B2 (en) * 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
CA2562833A1 (en) * 2004-04-27 2005-11-03 Galapagos N.V. Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
US20120150023A1 (en) * 2007-08-06 2012-06-14 Kaspar Roger L Microneedle arrays for active agent delivery
TR201905477T4 (tr) * 2011-01-24 2019-05-21 Anterios Inc Nano-parçacık bileşimler.
CN104080924A (zh) * 2011-08-16 2014-10-01 昂科赛特公司 用于治疗和诊断乳腺癌的方法和组合物
WO2016094732A1 (en) * 2014-12-10 2016-06-16 Transderm, Inc. METHODS OF TREATING PAIN AND/OR ITCH WITH SMALL MOLECULE INHIBITORS TARGETING AN mTOR PATHWAY

Similar Documents

Publication Publication Date Title
CN114681621B (zh) 肽寡核苷酸缀合物
DK2694652T3 (en) MEDICINE FOR LIVER REGENERATION AND FOR THE TREATMENT OF LIVER FAILURE
Simonson et al. MicroRNA therapeutics: the next magic bullet?
Ling Non-coding RNAs: therapeutic strategies and delivery systems
US9458459B2 (en) Methods for enhancing utrophin production via inhibition of microRNA
JP6944942B2 (ja) ＩＬ４Ｒα、ＴＲＰＡ１、またはＦ２ＲＬ１を標的とするＲＮＡ複合体を用いたアトピー性皮膚炎および喘息の治療
JP2018531600A5 (enExample)
CN105658797A (zh) 用于调节rna的组合物和方法
JP2015518710A (ja) ヘモグロビン遺伝子ファミリー発現を調節するための組成物及び方法
JP2015523855A (ja) Ａｐｏａ１及びａｂｃａ１発現を調節するための組成物及び方法
JP2016502858A5 (enExample)
ES3001019T3 (es) Inhibidores del MICRO-RNA 22
JP2022169627A5 (enExample)
JP7553036B2 (ja) ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤
US12016930B2 (en) Skin-permeating carrier containing nucleic acid complex and use thereof
US20180055869A1 (en) Compositions and methods for modulating rna
CN114901823A (zh) 诱导外显子50的跳读的反义核酸
CN104024413B (zh) 小干扰RNA及其应用和抑制plk1基因表达的方法
CN119365598A (zh) 用于治疗单基因神经发育障碍的组合物和方法
CN115210376A (zh) 诱导外显子51的跳读的反义核酸
JP2011505798A5 (enExample)
Suryawanshi et al. A simple alternative to stereotactic injection for brain specific knockdown of miRNA
JP2025504474A5 (enExample)
ES2374244A1 (es) MicroRNA útil para el tratamiento de canalopatías arritmogénicas.
US20260092085A1 (en) Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy